Table 2.
Negative control group | Positive control group | Test group | |
---|---|---|---|
BW (kg) | |||
1 d | 7.43 ± 0.45 | 7.46 ± 0.37 | 7.46 ± 0.37 |
7 d | 9.27 ± 0.50 | 10.12 ± 0.52 | 10.29 ± 0.56 |
21 d | 14.23 ± 0.85a | 16.32 ± 0.77ab | 16.89 ± 0.72b |
35 d | 21.14 ± 1.14a | 24.05 ± 0.80ab | 24.80 ± 1.12b |
ADG (g/d) | |||
1–7 d | 262.90 ± 19.92A | 379.21 ± 25.89B | 404.65 ± 28.69B |
8–21 d | 354.31 ± 27.30a | 438.49 ± 23.44b | 462.91 ± 26.66b |
22–35 d | 493.53 ± 37.61 | 552.23 ± 17.83 | 565.18 ± 31.71 |
1–35 d | 391.71 ± 22.69a | 472.13 ± 14.65b | 492.17 ± 24.01b |
ADFI (g/d) | |||
1–7 d | 427.73 ± 20.31 | 478.21 ± 22.97 | 465.48 ± 25.29 |
8–21 d | 527.42 ± 37.23 | 596.90 ± 30.87 | 614.75 ± 36.64 |
22–35 d | 810.66 ± 44.08 | 883.56 ± 30.00 | 953.38 ± 65.27 |
1–35 d | 620.78 ± 32.55 | 687.83 ± 27.65 | 720.35 ± 44.60 |
FCR | |||
1–7 d | 1.70 ± 0.15Aa | 1.29 ± 0.07ABb | 1.16 ± 0.04Bab |
8–21 d | 1.51 ± 0.07 | 1.36 ± 0.03 | 1.34 ± 0.06 |
22–35 d | 1.65 ± 0.05 | 1.61 ± 0.05 | 1.69 ± 0.06 |
1–35 d | 1.59 ± 0.04Aa | 1.45 ± 0.02Bab | 1.46 ± 0.03ABb |
Diarrhea rate (%) | |||
1–7 d | 11.38 ± 4.91 | 8.16 ± 3.83 | 6.786 ± 2.22 |
8–14 d | 11.16 ± 5.13 | 7.41 ± 3.76 | 6.65 ± 1.72 |
15–21 d | 10.63 ± 3.43 | 4.11 ± 2.69 | 4.64 ± 2.47 |
1–21 d | 6.93 ± 2.45 | 4.29 ± 2.02 | 3.96 ± 1.28 |
BW, body weight; ADG, average daily gain; ADFI, average daily feed intake; FCR, feed conversion rate. Superscript letters a and b and superscript letters A and B in the same row indicate significant differences at p < 0.05 and p < 0.01, respectively.